01 Mar Coave Therapeutics
Posted at 15:53h
in
Rodolphe Clerval, CEO
April 10 | 1:45pm | Salone dei Cavalieri, Section 2
Paris, France
(Private)
Coave Tx is a genetic medicine company, based on a unique technology (ALIGATER) for functionalizing LNPs and AAVs, by conjugation of rationally designed ligands onto vectors surface, improving tissue targeting and efficient payload delivery. Our therapeutics pipeline, based on ALIGATER vectors, is focused on eyes and CNS disorders.
